LOOKING AT CLINICAL TRIALS AND MORE
Joint remodelling in inflammatory disease
Correspondence to:
Georg Schett, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Krankenhausstrasse 12, D-91054 Erlangen, Germany; georg.schett{at}med3.imed.uni-erlangen.de
Bone and the immune system share multiple interactions. The skeleton harbours the bone marrow and provides the niche for development of haematopoietic cells including the immune system. The immune system provides cells as well as molecular signals, which regulate bone homeostasis. Understanding the cellular and molecular regulation of the tight interaction between bone and the immune system is crucial for understanding the changes of skeletal architecture during inflammation. Whereas a short and self-limited activation of the immune system has no clinically meaningful effect on bone, prolonged immune activation as found in chronic inflammatory disease inevitably leads to bone wasting.
Abbreviations: AS, ankylosing spondylitis; BMPs, bone morphogenic proteins; DKK, Dickkopf; MCSF, macrophage colony-stimulating factor; OPG, osteoprotegerin; PsA, psoriatic arthritis; RA, rheumatoid arthritis; RANKL, receptor-antagonist of NF-kB ligand; Wnt, wingless proteins
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
